Cyclophosphamide Capsule
Cyclophosphamide is a compounded formulation containing Cyclophosphamide, prepared by Mixlab for veterinary use. Available by prescription.
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Cyclophosphamide is a nitrogen mustard-class alkylating agent utilized in veterinary medicine primarily as a component of chemotherapy protocols. It is a prescription medication available for use in dogs and cats, frequently considered by veterinarians for patients presented with lymphoma, leukemias or certain immune-mediated diseases. At a pharmacological level, cyclophosphamide is a prodrug that is activated in the liver to form active metabolites. These metabolites act by cross-linking bacterial DNA strands, which manages the ability of rapidly dividing cells to replicate. This mechanism provides a method for managing the progression of cancerous cell populations or the overactive immune response in specific systemic diseases. Your veterinarian will determine the clinical appropriateness of cyclophosphamide based on diagnostic findings such as biopsy results or specialized blood work.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of cyclophosphamide include localized digestive changes such as vomiting or a temporary decrease in appetite. Some animals may exhibit behavioral shifts including lethargy or changes in their hair coat. A high-priority clinical consideration is sterile hemorrhagic cystitis (bladder irritation), which can occur due to the presence of acrolein, a byproduct of the medication; your veterinarian will provide guidance on how to manage this risk through hydration and monitoring. Owners should monitor their pet for any unusual signs of bloody urine, painful urination or persistent energy shifts and contact their veterinarian promptly with any concerns. This medication is typically used with extra caution or avoided in patients with known bone marrow suppression or severe renal impairment. Significant interactions can occur if cyclophosphamide is administered concurrently with other chemotherapy agents or certain medications that influence liver enzymes. Because chemotherapy requires precise oversight, your veterinarian is the right person to provide guidance on the necessary duration of use and the proper monitoring schedule to ensure the management approach remains suitable for your pet's specific profile.
Yes. Cyclophosphamide is a prescription chemotherapy medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped to your home.
Yes. While cyclophosphamide is available in commercial tablet formats, Mixlab specializes in compounding the active ingredient into customized strengths or flavored capsules to suit the specific needs of your pet. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians discuss cyclophosphamide for lymphoma because it acts directly on the DNA of rapidly dividing cells. By managing the ability of these cells to replicate, the medication provides a method for managing the progression of the disease as part of a multi-drug protocol.
Chemotherapy medications require careful handling to minimize human contact with the medication. Your veterinarian will provide guidance on wearing gloves, avoiding crushing tablets and properly managing your pet's waste during the management course. Always follow the professional safety instructions provided by your veterinarian.
